Lang Li

FDA

1 appearance in the program

Sessions & presentations

Presentation: Panel discussion (FDA and Pharmaceutical Industry): Regulatory and industry Perspectives on Biomarker-Adaptive Trial Designs

Parallel · Fri, Sep 18 , 8:30 AM

Panelist